Insights on Clinical Trials
-
Outsourcing Vendor Red Flag #2: Oversight And Process
11/8/2023
Depth of management typically is less about ensuring your trial progresses smoothly and more about hiding the CRO’s deficiencies or appeasing its own stakeholders.
-
Outsourcing Vendor Red Flags: Bids And Contracts
11/8/2023
Adept CRO communication doesn’t just indicate the vendor’s ability to deliver a thoughtful bid; it demonstrates their ability to analyze, operationalize, and optimize a plan.
-
The Power And Potential Of RBM In Clinical Trials
11/8/2023
Risk-based monitoring increases overall trial oversight by balancing “must-do” data collection and “nice-to-have” data against site and patient burden — and, more importantly, patient safety.
-
Driving Down COGS: Breaking Down Automated Manufacturing
11/7/2023
While working to optimize discrete process steps is important, achieving CAR-T scalability requires finding ways to perform some steps concurrently, necessitating a more holistic approach to innovation.
-
Navigating The Biotech Landscape Amidst Covid-19 And Beyond
11/7/2023
Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.
-
Infectious Diseases – 2018-2023 Global Clinical Trial Landscape
11/7/2023
Gain in-depth insights into infectious diseases-based clinical trials and be better informed about trends, regional disparities, technological advancements, and financing dynamics.
-
Rare Disease – 2018-2022 Global Clinical Trial Landscape
11/7/2023
Discover why the collaboration and expertise of organizations are vital in advancing rare disease research and improving the lives of millions affected.
-
Dyslipidaemia – 2023 Global Clinical Trial Landscape
11/7/2023
While APAC is at the forefront of dyslipidaemia research, gain insight into pharmaceutical companies' continued new treatment developments and innovative therapies.
-
Non-Small Cell Lung Cancer: Global Clinical Trial Landscape
11/7/2023
Unearth how targeted medicines and immunotherapy have emerged as viable treatment options, offering hope for improved outcomes and quality of life for NSCLC patients.
-
Hemophilia - Global Clinical Trial Landscape
11/7/2023
Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.